combination drug therapy for peptic ulcer disease
Báo cáo y học: " WT1 PEPTIDE VACCINATION IN COMBINATION WITH IMATINIB THERAPY FOR A PATIENT WITH CML IN THE CHRONIC PHASE"
... imatinib therapy for a CML patient. A 51 year-old male with CML in CP, who showed a resistance against imatinib therapy for 2.5 years, began to be treated with 9mer modified-type WT1 peptides in combination ... μg/ml for l antibody periments Int. J. Med. Sc Figure 2. WT performed in a the 20th admi PE-modified-t y for WT1 pept peptide/MHC 3. Kinetics o Comple blood cell dif WT1 peptid therapy. ... anti-tumor immunotherapy as in this case. These data suggested the possible usefulness of treatment for suppressing the function of regulatory T cells in combination with anti-tumor immunotherapy in- cluding...
Ngày tải lên: 26/10/2012, 09:39
Báo cáo y học: "Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome"
... been obtained in therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome (APS). We therefore compared single antiplatelet therapy and a combination of antiplatelet ... in the single antiplatelet therapy group, and one subcutaneous hemorrhage was found in the combination therapy group. As for the patient in the single antiplatelet therapy group who developed ... assigned to either single antiplatelet therapy (aspirin 100 mg) or a combination of antiplatelet and an- ticoagulation therapy (target INR: 2.0-3.0; mean 2.4±0.3) for the secondary prevention of stroke...
Ngày tải lên: 26/10/2012, 09:48
Tài liệu Báo cáo Y học: Receptor crosstalk Implications for cardiovascular function, disease and therapy ppt
... practical significance for human disease conditions. The second category of cardiac diseases comprises disorders, such as left ventricular dysfunction from valvular heart diseases or hypertension ... failure and in human disease strongly argues for the existence of a 1 -AR as a purposeful and productive resource for adaptive regulation of contrac- tility in response to cardiac disease. Although ... conditions in the most appropriate fashion in disease. Implications of receptor crosstalk for pharmacological treatment of cardiac disease Traditionally, the search for the most appropriate thera- peutic...
Ngày tải lên: 21/02/2014, 15:20
Clinical Drug Therapy: Rationales for Nursing Practice, Ninth Edition docx
... 866 Effects of Drugs on the Digestive System 866 60 Drugs Used for Peptic Ulcer and Acid Reflux Disorders . . . . . . . . . 867 Overview 867 Peptic Ulcer Disease 867 Types of Drugs 869 Principles of Therapy ... the drug. DRUG PREPARATIONS AND DOSAGE FORMS Drug preparations and dosage forms vary according to the drug s chemical characteristics, reason for use, and route of administration. Some drugs ... many drug drug interactions is altered drug metabolism. For example, drugs metabolized by the same enzymes may compete for enzyme binding sites and there may not be enough binding sites for two...
Ngày tải lên: 29/03/2014, 11:21
Báo cáo khoa học: Active-site-specific chaperone therapy for Fabry disease Yin and Yang of enzyme inhibitors pptx
... quality of life. Perspective of DGJ treatment for Fabry disease To date, ERT is the only available Food and Drug Administration approved therapy for Fabry disease. ERT has clear advantages in that ... weightặday )1 for 2 weeks [47]. No apparent toxic effects were observed in transgenic mice treated with DGJ for 140 days, indicating that DGJ is well toler- ated in mice. ASSC therapy for Fabry disease ... or end-stage renal failure [8]. The prevalence of Fabry disease is estimated at 1 : 40 000 for the classic form. The incidence of the variant form of Fabry disease was found to be higher. Screening of various...
Ngày tải lên: 30/03/2014, 03:20
gene therapy for liver disease
... Ideally, however, gene therapy can be accomplished to correct genetic defects by in vivo methods. Ideally, a vehicle for in vivo gene therapy for the treatment of liver disease must be liver specific, ... acquired diseases such as viral infections of the liver. ã There are two basic approaches for gene transfer into hepatocytes: ex vivo and in vivo strategies. ã A vehicle for in vivo gene therapy for ... days posttreatment. The decline lasted for approximately 2 weeks, after which there was a gradual rise in DNA levels. 172 GENE THERAPY FOR LIVER DISEASE therapy is that only dividing cells are...
Ngày tải lên: 10/04/2014, 22:11
Optimal Medical Therapy with or without PCI for Stable Coronary Disease potx
Ngày tải lên: 27/06/2014, 00:20
Báo cáo y học: " Chitosan Interferon-c Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses" pps
Ngày tải lên: 08/08/2014, 21:20
